ELSIE BIOTECHNOLOGIES

HQ - San Diego

Summary

Elsie is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics by integrating discovery, development, and delivery to potentially increase potency, decrease toxicity, and optimise delivery.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 39 M

Avg. Deal Size£ 39 M

Market Context

Senior Management

Kevin Green
COO

Sort

06 Jun 2024|United States|Biotechnology

Target: ELSIE BIOTECHNOLOGIES

Bidder: GLAXOSMITHKLINE PLC

3 Service Providers

1 Target | 2 Bidder

16 Dealmakers

1 Target | 15 Bidder

£ 39 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy